Skip to main content

Peer Review reports

From: Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: a case report

Original Submission
4 Jan 2023 Submitted Original manuscript
5 Jan 2023 Reviewed Reviewer Report - Arjun Singh
18 Jan 2023 Reviewed Reviewer Report - Mihai Marinca
23 Jan 2023 Reviewed Reviewer Report - Mohamad K. Abou Chaar
9 Mar 2023 Author responded Author comments - Hiroaki Iijima
Resubmission - Version 2
9 Mar 2023 Submitted Manuscript version 2
16 Mar 2023 Reviewed Reviewer Report - Paritharsh Ghantasala
13 Jul 2023 Author responded Author comments - Hiroaki Iijima
Resubmission - Version 3
13 Jul 2023 Submitted Manuscript version 3
25 Jul 2023 Reviewed Reviewer Report - Paritharsh Ghantasala
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
30 Jul 2023 Editorially accepted
12 Sep 2023 Article published 10.1186/s13256-023-04106-6

You can find further information about peer review here.

Back to article page